Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection
Authors:
- 28 August 2014
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 30 (2) , 421-433
Abstract
Background and Aim: Downregulation of the WW domain containing oxidoreductase (WWOX) has been reported to be involved in tumorigenesis in several neoplasms. This study sought to investigate the expression and role of WWOX in intrahepatic cholangiocarcinoma (ICC).Methods: WWOX expression was measured by quantitative real‐time polymerase chain reaction (PCR), immunoblot, immunofluorescence, and immunohistochemistry. The prognostic significance was assessed by Kaplan–Meier and Cox regression analyses. The role of WWOX in proliferation, anchorage‐independent growth, gene expression regulation, and tumorigenesis was assessed by WWOX re‐expression using lentivirus. Methylation‐specific PCR was performed to evaluate the methylation status of the WWOX gene regulatory region. A DNA methyltransferase inhibitor, 5‐aza‐2′‐deoxycytidine (AZA), was used to activate the endogenous WWOX gene in ICC cells both in vitro and in vivo.Results: The expression of WWOX in ICC tissues was much lower than that in nontumorous samples and showed reverse correlation with proliferative status. Restoration of WWOX expression resulted in suppression of the growth of WWOX‐deficient ICC cells through activation of the intrinsic apoptotic signaling pathway, but did not affect growth of WWOX‐sufficient human intrahepatic biliary epithelial derived non‐cancer cells. Multivariate analyses revealed that downregulation of WWOX was an unfavorable predictor for overall survival and cumulative recurrence rates. The WWOX gene regulatory region was frequently methylated in ICC tissues and cell lines, and intratumoral WWOX restoration, through AZA injection, suppressed tumor growth in nude mice.Conclusion: Downregulation of WWOX may occur as a result of hypermethylation and implies a poor prognosis in ICC; WWOX re‐expression may be a potential molecular therapeutic target for ICC.Keywords
Funding Information
- National Natural Science Foundation of China (81170415)
This publication has 29 references indexed in Scilit:
- CholangiocarcinomaThe Lancet, 2014
- Pathogenesis, Diagnosis, and Management of CholangiocarcinomaGastroenterology, 2013
- A functional copy number variation in the WWOX gene is associated with lung cancer risk in ChineseHuman Molecular Genetics, 2013
- Evidences that the polymorphism Pro‐282‐Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinomaInternational Journal of Cancer, 2011
- Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patientsCancer, 2010
- Intrahepatic CholangiocarcinomaSurgical Clinics of North America, 2010
- Fragile histidine triad protein, WW domain‐containing oxidoreductase protein Wwox, and activator protein 2γ expression levels correlate with basal phenotype in breast cancerCancer, 2009
- The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOXJournal of Hepatology, 2008
- Intrahepatic CholangiocarcinomaAnnals of Surgery, 2008
- Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based StudyAnnals of Surgical Oncology, 2007